Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies

Triple-negative breast cancer (TNBC) cells are deficient in estrogen, progesterone and ERBB2 receptor expression, presenting a particularly challenging therapeutic target due to their highly invasive nature and relatively low response to therapeutics. There is an absence of specific treatment strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina, Mauricio A., Oza, Goldie, Sharma, Ashutosh, Arriaga, L.G., Hernández Hernández, José Manuel, Rotello, Vincent M., Ramirez, Jose Tapia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143295/
https://www.ncbi.nlm.nih.gov/pubmed/32245065
http://dx.doi.org/10.3390/ijerph17062078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143295/
https://www.ncbi.nlm.nih.gov/pubmed/32245065
http://dx.doi.org/10.3390/ijerph17062078

Ejemplares similares